Pharma News

San Diego biotech Neomorph begins first clinical trial for molecular glue NEO-811 to treat clear cell renal cell carcinoma, putting claim to the test.

Alteogen's once-monthly obesity drug showed weight loss matching retatrutide and less yo-yo regain in preclinical tests, applying NexP platform.

Apotex and Grünenthal finalised a licensing agreement granting Apotex exclusive Canadian rights to Nebido, a long-acting injectable testosterone therapy.

Ohio State and IIT Madras researchers developed PURE, an AI framework using reinforcement learning to generate drug-like molecules for synthesis.

CNIO study shows triple KRAS inhibition cures pancreatic cancer in mice, but experts caution rigorous clinical trials needed to assess efficacy in humans.

SEQSTER and Praxis expand partnership to accelerate clinical trials and RWE generation for CNS disorders like epilepsy using real-world patient data.

UMSOM and ENA Respiratory launch Phase 2 trial of INNA-051, a TLR2/6 agonist intranasal spray to prevent respiratory viruses in adults.

Relay Thera’s zovegalisib wins FDA Breakthrough Therapy designation for PIK3CA mutant, HR+/HER2- breast cancer with fulvestrant.

Experts argue reducing liver fat is not enough for MASH drugs. Preclinical approaches must verify hepatocellular carcinoma suppression and long-term data.

FDA starts accepting PreCheck applications to streamline US pharmaceutical manufacturing facilities, confirmed by Marty Makary to boost security.

GSK5764227 (HS-20093) is an experimental HER2-targeted antibody-drug conjugate studied in the Phase I ARTEMIS-001 clinical trial for solid tumors.

Zydus and AvKARE recall thousands of cholesterol drug bottles nationwide due to manufacturing defects, subpotency, and dissolution issues per FDA.